Sonja Krösser - Free People Check with News, Pictures & Links

	Germany Heidelberg

	Research Clinical Development Vice President Novaliq Announces Announces First Patient Novaliq to Present

Images of Sonja Krösser

(0 from 0 )

News

(1 - 4 from 12

–show all

)

Novaliq to Present Scientific and Clinical elEconomista.eswww.eleconomista.es › empresas-finanzas › noticias › Novaliq-to-Present-S...

www.eleconomista.es

... water-free platform technology with researchers, clinicians, and industry," said Sonja Krösser, PhD, VP Preclinical and Clinical Development, Novaliq.

Novaliq Announces First Patient Randomized in the Phase 3...

www.ots.at

Dec 8, · "The initiation of this second registrational trial represents a key milestone for both CyclASol® and our company," says Sonja Krösser, PhD, ...

Bourse - Novaliq présentera une recherche scientifique et clinique...

www.boursica.com

... cliniciens et l'industrie », a déclaré Sonja Krösser, PhD, vice-présidente, développement préclinique et clinique de Novaliq. « Notre dévouement à la science est à la base de l'avancement de notre pipeline unique et du développement de produits innovants qui aident les médecins à mieux répondre aux ...

NOVALIQ verstärkt die Geschäftsleitung durch die Berufung von...

www.finanznachrichten.de

NOVALIQ GmbH, ein spezialisiertes pharmazeutisches Unternehmen mit einer disruptiven Drug-Delivery-Plattform, die schlecht lösliche Arzneimittel in wirksame...

Telephone & Addresses

11880.com: com - Christian Kroesser in München

Alexander Krösser · Sonja Krösser · Andreas Krösser · Johny Krösser · Wolfgang Krösser · Mathias Krößer · Zenta Krößer · Martin Krößer · Walter und Irene ...

Sonja KrösserHeidelberg

telefonbuch-suche.com

Die Anschrift von Sonja Krösser lautetin Heidelberg. Baden-Württemberg in Deutschland. Die Telefonnummer von Sonja Krösser ist die...

11880.com: Krösser in Heidelberg im Telefonbuch von

Sonja Krösser. X. England · Italia · Unternehmen · Referenzen · Nutzungsbedingungen · Impressum · Datenschutz · AGB; Folge uns: App downloaden.

Network Profiles

LinkedIn: Sonja Krösser | LinkedIn

Sonja Krösser. Head Clinical Development bei Novaliq GmbH. Ort Frankfurt am Main und Umgebung, Deutschland Branche Pharmazie

Mememoir Sonja Krösser

www.mememoir.org

Investigation of the impact of sarizotan on the pharmacokinetics of levodopa. Krösser, S., Neugebauer, R., Chassard, D., Kovar, A. Biopharm. Drug. Dispos ...

Interests

Novaliq Announces More than 50% Patients Enrolled in CyclASol ...markets.businessinsider.com › news › stocks › novaliq-announces-more-th...

markets.businessinsider.com

... despite the COVID-19 pandemic environment," said Sonja Krösser, Ph.D., Vice President Clinical Development at Novaliq. "Patients had the opportunity to ...

Novaliq to Present Scientific and Clinical Research During the

www.businesswire.com

Novaliq GmbH will present four scientific posters at the Association for Research in Vision and Ophthalmology Meeting in Honolulu April 29-May 3.

Novaliq to Present Scientific and Clinical Research Business Wirewww.businesswire.com › news › home › Novaliq-to-Present-Scientific-and...

www.businesswire.com

Apr 24, · ... clinicians, and industry,” said Sonja Krösser, PhD, VP Preclinical and Clinical Development, Novaliq. “Our dedication to science is the ...

Business Profiles

Researchgate: Sonja Krösser

Heidelberg, Germany

Scientific Publications

Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease—A...

www.ncbi.nlm.nih.gov

· Philipp Steven, 1,, 2 Dieter Scherer, 3 Sonja Krösser, 3 Michael Beckert, 4 Claus Cursiefen, 1 and Thomas Kaercher 5

Publications

(1 - 4 from 6

–show all

)

Publications Authored by Sonja Krösser | PubFacts

www.pubfacts.com

Publications Authored by Sonja Krösser

Sonja Krösser's Research | CureHunter

www.curehunter.com

Sonja Krösser Selected Research. Sonja Krösser Research Topics. Disease. 1, Parkinson Disease (Parkinson's Disease) , Dyskinesias (Dyskinesia)

Sonja Kroesser | PubFacts

www.pubfacts.com

Sonja Kroesser

Investigation of sarizotan’s impact on the pharmacokinetics of probe...

link.springer.com

The 5HT1A receptor agonist sarizotan is in clinical development for the treatment of dyskinesia, a potentially disabling complication in Parkinson’s

Miscellaneous

(1 - 20 from 38

–show all

)

NOVALIQ Strengthens Executive …

finance.yahoo.com

· NOVALIQ Strengthens Executive Management Team with the Appointment of Gabriela Burian, MD, MPH, as Chief Medical Officer Sonja Krösser, PhD, ...

Novaliq Completes Enrollment of Second Phase Yahoo Financewww.yahoo.com › now › novaliq-completes-enrollment-second-phase

www.yahoo.com

Aug 10, · ... earlier phases of the development program ," said Sonja Krösser, Ph.D., Vice President Pre-Clinical and Clinical Development, Novaliq.

Novaliq to Present Scientific and Clinical Research Yahoo Finance

finance.yahoo.com

“We are proud to share and discuss the scientific data on our innovative and water-free platform technology with researchers, clinicians, and industry,” said Sonja Krösser, PhD, VP Preclinical and Clinical Development, Novaliq. “Our dedication to science is the basis for advancing our unique pipeline and ...

A Water-free 0.1% Cyclosporine A Solution for Physician's Weeklywww.physiciansweekly.com › ...

www.physiciansweekly.com

Sep 6, · ... L Wirta,Eugene McLaurin,Blair E Boehmer,Joseph B Ciolino,Alice S Meides,Thomas Schlüter,George W Ousler,Dale Usner,Sonja Krösser

Das erste* Prostaglandin ohne Konservierungsmittel DOG Eﬀektive...

docplayer.org

... non-interventional study Elisabeth M. Messmer (München), Thomas Kaercher (Heidelberg), Kathleen Kunert (Erfurt), Wolfgang Schrems, Johannes Menzel- Severing (Erlangen), Norbert Schrage (Köln), Albert J. Augustin (Karlsruhe), Ivanka Dacheva (Heidelberg), Gerd Geerling (Düsseldorf), Sonja Krösser (Heidelberg), ...

DOG Berlin - PDF

docplayer.org

61 FrF Altersbezogene Wirksamkeit von 0,05 % Ciclosporin/F4H5 und 0,1 % Ciclosporin (Ikervis) im experimentellen Trockenen Auge Uta Gehlsen, Tobias Braun (Köln), Sonja Krösser (Heidelberg), Philipp Steven (Köln) von Graefe Saal Freitag, :45-11:00 Quo vadis Glaukomdiagnostik? Fr05 Symposien Wiss.

CyclASol Second Phase 3 Study for DED Ready to Roll - mivisionwww.mivision.com.au › › cyclasol-second-phase-3-study-for-ded...

mivision.com.au

Aug 11, · ... earlier phases of the development program,” said Sonja Krösser, Ph.D., Vice President Pre-Clinical and Clinical Development, Novaliq.

Informationen gesucht:Sonja

german-directory.review

Suche nach Telefonnummer für Sonja

Industry Spotlight: Novaliq - OCULAR SURFACE ACADEMYocularsurfaceacademy.com › podcast › industry-spotlight-novaliq

ocularsurfaceacademy.com

Mar 15, · Sonja Krösser, PhD, Novaliq's Head of Clinical Development, discusses research around the late-stage compounds NOV03 and CyclASol.

Klinische Monatsblätter für Augenheilkunde - Thieme

www.thieme.de

A. Langenbucher, B. Seitz, N. Szentmáry. Amnionmembransuspension und autologes Serum – spielt der Inhalt eine Rolle für die Wundheilung? 662 Steven, Philipp, Tobias Braun, Sonja Krösser,. Uta Gehlsen. Einfluss von Alterung auf Schweregrad und antient- zündliche Therapie des experimentellen Trockenen. Auges ...

NOVALIQ verstärkt die Geschäftsleitung durch die Berufung von...

www.pharma-zeitung.de

Sonja Krösser, PhD, Vice President für präklinische und klinische Entwicklung, wird auch weiterhin die Entwicklung von Mitteln für trockene ...

NOVALIQ renforce son équipe de haute direction avec la nomination de...

www.itespresso.fr

exploitant la puissance de la technologie propriétaire EyeSol® de. NOVALIQ, qui optimise la biodisponibilité, la stabilité et l'innocuité topiques de médicaments généralement insolubles ou instables.” Sonja Krösser, PhD, vice-présidente du développement préclinique et clinique, continuera de diriger les développements ...

Investigation of sarizotan’s impact on the pharmacokinetics of probe...

www.infona.pl

Sonja Krösser, Roland Neugebauer, Hugues Dolgos, Markus Fluck, Karl-Ludwig Rost, Andreas Kovar · Details · Contributors · Fields of science ...

Novaliq Announces First Patient Randomized PipelineReview.compipelinereview.com › index.php › Proteins-and-Peptides › 3-Trial-of-Cycl...

pipelinereview.com

Nov 9, · ... a major milestone in advancing our clinical development of CyclASol®,” says Sonja Krösser, PhD, VP Clinical Development at Novaliq GmbH.

Novaliq Announces First Patient Randomized in Its ESSENCE ...www.firstwordmedtech.com › node

www.firstwordmedtech.com

Nov 9, · ... a major milestone in advancing our clinical development of CyclASol®,"says Sonja Krösser, PhD, VP Clinical Development at Novaliq GmbH.

Novaliq Announces First Patient Randomized in the Ora Clinicalwww.oraclinical.com › resource › novaliq-announces-first-patient-randomi...

www.oraclinical.com

Dec 8, · “The initiation of this second registrational trial represents a key milestone for both CyclASol® and our company,” says Sonja Krösser, PhD, ...

Novaliq Completes Enrollment of Second Phase Samachar Livewww.samacharlive.com › novaliq-completes-enrollment-of-second-phase-3...

samacharlive.com

Aug 10, · ... earlier phases of the development program ,” said Sonja Krösser, Ph.D., Vice President Pre-Clinical and Clinical Development, Novaliq.

Related search requests for Sonja Krösser

People
Forename "Sonja" (12477)
Name "Krösser" (2)

sorted by relevance / date

Advanced Search

Save as document

Search name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Sonja Krösser Free People Check

Images of Sonja Krösser

Telephone & Addresses

Network Profiles

Interests

Business Profiles

Related Documents

Scientific Publications